10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 273 filers reported holding 10X GENOMICS INC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,562,049 | +28.4% | 80,311 | +269.3% | 0.00% | +50.0% |
| Q4 2023 | $1,216,850 | -97.1% | 21,745 | -97.1% | 0.00% | -98.1% |
| Q1 2023 | $41,388,425 | +2934.3% | 741,861 | +2360.9% | 0.10% | +2500.0% |
| Q2 2022 | $1,364,000 | -61.8% | 30,146 | +52.6% | 0.00% | -77.8% |
| Q1 2021 | $3,575,000 | -57.3% | 19,751 | -66.6% | 0.02% | -60.9% |
| Q4 2020 | $8,363,000 | +629.1% | 59,063 | +359.7% | 0.05% | +360.0% |
| Q2 2020 | $1,147,000 | – | 12,848 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 2,106,757 | $117,894,122 | 100.00% |
| Blue Water Life Science Advisors, LP | 194,500 | $10,884,220 | 9.53% |
| Sands Capital Ventures, LLC | 481,770 | $26,959,849 | 7.50% |
| Meritech Capital Associates V L.L.C. | 494,236 | $27,657,447 | 6.73% |
| Decheng Capital LLC | 359,554 | $20,120,642 | 5.62% |
| Iron Triangle Partners LP | 479,374 | $26,825,769 | 3.47% |
| Brown Capital Management | 3,527,297 | $197,387,540 | 2.96% |
| Freshford Capital Management, LLC | 305,798 | $17,112,456 | 2.78% |
| SVB WEALTH LLC | 1,446,552 | $80,949,066 | 1.97% |
| Capital Impact Advisors, LLC | 23,594 | $1,320,320 | 1.74% |